Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression
NCT00285766
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
300
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depression
Interventions
DRUG:
Selegiline Transdermal System
Sponsor
Somerset Pharmaceuticals